Potential of Favipiravir and Minocycline Combination Therapy for COVID-19
Since the outbreak and spread of COVID-19 in Japan, we have been investigating and anticipating the possibility of anti-inflammatory effects in combination therapy with antibacterial and antiviral agents. Minocycline is an antibacterial agent that has been validated for its anti-inflammatory effects...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mary Ann Liebert
2022-01-01
|
| Series: | Re:GEN Open |
| Subjects: | |
| Online Access: | https://www.liebertpub.com/doi/full/10.1089/REGEN.2021.0037 |